{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T14:35:48Z","timestamp":1742913348294,"version":"3.40.3"},"publisher-location":"Cham","reference-count":71,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783319216829"},{"type":"electronic","value":"9783319216836"}],"license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.1007\/978-3-319-21683-6_2","type":"book-chapter","created":{"date-parts":[[2015,12,20]],"date-time":"2015-12-20T16:46:01Z","timestamp":1450629961000},"page":"15-28","source":"Crossref","is-referenced-by-count":0,"title":["Understanding Cancer Stem Cells Biology to Get Rid of Tumours"],"prefix":"10.1007","author":[{"given":"Jos\u00e9","family":"Bragan\u00e7a","sequence":"first","affiliation":[]},{"given":"Gisela","family":"Machado-Oliveira","sequence":"additional","affiliation":[]},{"given":"Ivette","family":"Pacheco-Leyva","sequence":"additional","affiliation":[]},{"given":"Ana Catarina","family":"Matias","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"2_CR1","doi-asserted-by":"publisher","first-page":"7634","DOI":"10.1073\/pnas.78.12.7634","volume":"78","author":"G Martin","year":"1981","unstructured":"Martin G (1981) Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A 78:7634\u20137638","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2_CR2","first-page":"15415","volume":"292","author":"M Evans","year":"1981","unstructured":"Evans M, Kaufman M (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature 292:15415\u201315416","journal-title":"Nature"},{"key":"2_CR3","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","volume":"282","author":"JA Thomson","year":"1998","unstructured":"Thomson JA et al (1998) Embryonic stem cell lines derived from human blastocysts. Science 282:1145\u20131147","journal-title":"Science"},{"key":"2_CR4","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.stem.2010.11.016","volume":"7","author":"N Barker","year":"2010","unstructured":"Barker N, Bartfeld S, Clevers H (2010) Tissue-resident adult stem cell populations of rapidly self-renewing organs. Cell Stem Cell 7:656\u2013670","journal-title":"Cell Stem Cell"},{"key":"2_CR5","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S0092-8674(03)00687-1","volume":"114","author":"AP Beltrami","year":"2003","unstructured":"Beltrami AP et al (2003) Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114:763\u2013776","journal-title":"Cell"},{"key":"2_CR6","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1146\/annurev.cellbio.042308.113256","volume":"25","author":"H Suh","year":"2009","unstructured":"Suh H, Deng W, Gage FH (2009) Signaling in adult neurogenesis. Annu Rev Cell Dev Biol 25:253\u2013275","journal-title":"Annu Rev Cell Dev Biol"},{"key":"2_CR7","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.cell.2008.01.038","volume":"132","author":"SJ Morrison","year":"2008","unstructured":"Morrison SJ, Spradling AC (2008) Stem cells and niches: mechanisms that promote stem cell maintenance throughout fife. Cell 132:598\u2013611","journal-title":"Cell"},{"key":"2_CR8","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1158\/0008-5472.CAN-05-3153","volume":"66","author":"MS Wicha","year":"2006","unstructured":"Wicha MS, Liu S, Dontu G (2006) Cancer stem cells: an old idea \u2013 a paradigm shift. Cancer Res 66:1883\u20131890","journal-title":"Cancer Res"},{"key":"2_CR9","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.stem.2014.02.006","volume":"14","author":"A Kreso","year":"2014","unstructured":"Kreso A, Dick JE (2014) Evolution of the cancer stem cell model. Cell Stem Cell 14:275\u2013291","journal-title":"Cell Stem Cell"},{"key":"2_CR10","doi-asserted-by":"publisher","first-page":"045002","DOI":"10.1088\/1478-3975\/9\/4\/045002","volume":"9","author":"E Oron","year":"2012","unstructured":"Oron E, Ivanova N (2012) Cell fate regulation in early mammalian development. Phys Biol 9:045002","journal-title":"Phys Biol"},{"key":"2_CR11","doi-asserted-by":"publisher","first-page":"5709","DOI":"10.1073\/pnas.94.11.5709","volume":"94","author":"FA Brook","year":"1997","unstructured":"Brook FA, Gardner RL (1997) The origin and efficient derivation of embryonic stem cells in the mouse. Proc Natl Acad Sci U S A 94:5709\u20135712","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2_CR12","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1101\/gad.1689808","volume":"22","author":"J Yu","year":"2008","unstructured":"Yu J, Thomson JA (2008) Pluripotent stem cell lines. Genes Dev 22:1987\u20131997","journal-title":"Genes Dev"},{"key":"2_CR13","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/nature05972","volume":"448","author":"PJ Tesar","year":"2007","unstructured":"Tesar PJ et al (2007) New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 448:196\u2013199","journal-title":"Nature"},{"key":"2_CR14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nature05950","volume":"448","author":"IG Brons","year":"2007","unstructured":"Brons IG et al (2007) Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 448:191\u2013195","journal-title":"Nature"},{"key":"2_CR15","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1177\/1087057109336591","volume":"14","author":"VS Nirmalanandhan","year":"2009","unstructured":"Nirmalanandhan VS, Sittampalam GS (2009) Stem cells in drug discovery, tissue engineering, and regenerative medicine: emerging opportunities and challenges. J Biomol Screen 14:755\u2013768","journal-title":"J Biomol Screen"},{"key":"2_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1196\/annals.1349.001","volume":"1044","author":"JE Dick","year":"2005","unstructured":"Dick JE (2005) Acute myeloid leukemia stem cells. Ann N Y Acad Sci 1044:1\u20135","journal-title":"Ann N Y Acad Sci"},{"key":"2_CR17","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/35102167","volume":"414","author":"T Reya","year":"2001","unstructured":"Reya T et al (2001) Stem cells, cancer, and cancer stem cells. Nature 414:105\u2013111","journal-title":"Nature"},{"key":"2_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1475-2867-7-9","volume":"7","author":"J Sagar","year":"2007","unstructured":"Sagar J et al (2007) Role of stem cells in cancer therapy and cancer stem cells: a review. Cancer Cell Int 7:9","journal-title":"Cancer Cell Int"},{"key":"2_CR19","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.bpobgyn.2004.06.010","volume":"18","author":"K O\u2019Donoghue","year":"2004","unstructured":"O\u2019Donoghue K, Fisk NM (2004) Fetal stem cells. Best Pract Res Clin Obstet Gynaecol 18:853\u2013875","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2_CR20","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1002\/ccd.22016","volume":"73","author":"G Walther","year":"2009","unstructured":"Walther G, Gekas J, Bertrand OF (2009) Amniotic stem cells for cellular cardiomyoplasty: promises and premises. Catheter Cardiovasc Interv 73:917\u2013924","journal-title":"Catheter Cardiovasc Interv"},{"key":"2_CR21","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.tcb.2005.07.004","volume":"15","author":"JC Wang","year":"2005","unstructured":"Wang JC, Dick JE (2005) Cancer stem cells: lessons from leukemia. Trends Cell Biol 15:494\u2013501","journal-title":"Trends Cell Biol"},{"key":"2_CR22","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/nrc1694","volume":"5","author":"T Brabletz","year":"2005","unstructured":"Brabletz T et al (2005) Migrating cancer stem cells an integrated concept of malignant tumour progression. Nat Rev Cancer 5:744\u2013749","journal-title":"Nat Rev Cancer"},{"key":"2_CR23","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/nature11344","volume":"488","author":"G Driessens","year":"2010","unstructured":"Driessens G et al (2010) Defining the mode of tumour growth by clonal analysis. Nature 488:527\u2013530","journal-title":"Nature"},{"key":"2_CR24","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.canlet.2013.11.012","volume":"344","author":"ML O\u2019Connor","year":"2014","unstructured":"O\u2019Connor ML et al (2014) Cancer stem cells: a contentious hypothesis now moving forward. Cancer Lett 344:180\u2013187","journal-title":"Cancer Lett"},{"key":"2_CR25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.semcancer.2010.04.002","volume":"20","author":"M Shackleton","year":"2010","unstructured":"Shackleton M (2010) Normal stem cells and cancer stem cells: similar and different. Semin Cancer Biol 20:85\u201392","journal-title":"Semin Cancer Biol"},{"key":"2_CR26","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1101\/gad.1143403","volume":"17","author":"A Cozzio","year":"2003","unstructured":"Cozzio A et al (2003) Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev 17:3029\u20133035","journal-title":"Genes Dev"},{"key":"2_CR27","first-page":"173","volume":"4","author":"B Bose","year":"2014","unstructured":"Bose B, Shenoy SP (2014) Stem cell versus cancer and cancer stem cell: intricate balance decides their respective usefulness or harmfulness in the biological system. J Stem Cell Res Ther 4:173","journal-title":"J Stem Cell Res Ther"},{"key":"2_CR28","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nature12625","volume":"501","author":"RA Burrell","year":"2013","unstructured":"Burrell RA et al (2013) The causes and consequences of genetic heterogeneity in cancer evolution. Nature 501:338\u2013345","journal-title":"Nature"},{"key":"2_CR29","first-page":"1207","volume":"6","author":"M Wang","year":"2013","unstructured":"Wang M, Chiou S, Wu C (2013) Targeting cancer stem cells: emerging role of Nanog transcription factor. Onco Targets Ther 6:1207\u20131220","journal-title":"Onco Targets Ther"},{"key":"2_CR30","doi-asserted-by":"publisher","first-page":"5802","DOI":"10.4049\/jimmunol.1302140","volume":"191","author":"M Hasmim","year":"2013","unstructured":"Hasmim M et al (2013) Cutting edge: hypoxia-induced Nanog favors the intratumoral infiltration of regulatory T cells and macrophages via direct regulation of TGF-b1. J Immunol 191:5802\u20135806","journal-title":"J Immunol"},{"key":"2_CR31","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/2193-1801-2-301","volume":"2","author":"U Karsten","year":"2013","unstructured":"Karsten U, Goletz S (2013) What makes cancer stem cell markers different? Springerplus 2:301","journal-title":"Springerplus"},{"key":"2_CR32","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1242\/jcs.03450","volume":"120","author":"M Negrini","year":"2007","unstructured":"Negrini M et al (2007) MicroRNAs in human cancer: from research to therapy. J Cell Sci 120:1833\u20131840","journal-title":"J Cell Sci"},{"key":"2_CR33","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1002\/wrna.1229","volume":"5","author":"MY Shah","year":"2014","unstructured":"Shah MY, Calin GA (2014) MicroRNAs as therapeutic targets in human cancers. Wiley Interdiscip Rev RNA 5:537\u2013548","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"2_CR34","first-page":"72","volume":"1826","author":"B Bao","year":"2012","unstructured":"Bao B et al (2012) The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness. Biochim Biophys Acta 1826:72\u2013296","journal-title":"Biochim Biophys Acta"},{"key":"2_CR35","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/term.83","volume":"2","author":"S Bajada","year":"2008","unstructured":"Bajada S et al (2008) Updates on stem cells and their applications in regenerative medicine. J Tissue Eng Regen Med 2:169\u2013183","journal-title":"J Tissue Eng Regen Med"},{"key":"2_CR36","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.stem.2012.02.018","volume":"10","author":"AJ Wagers","year":"2012","unstructured":"Wagers AJ (2012) The stem cell niche in regenerative medicine. Cell Stem Cell 10:362\u2013369","journal-title":"Cell Stem Cell"},{"key":"2_CR37","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1083\/jcb.201102147","volume":"196","author":"P Lu","year":"2012","unstructured":"Lu P, Weaver VM, Werb Z (2012) The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol 196:395\u2013406","journal-title":"J Cell Biol"},{"key":"2_CR38","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1002\/stem.429","volume":"28","author":"KE Hovinga","year":"2010","unstructured":"Hovinga KE et al (2010) Inhibition of Notch signaling in glioblastoma targets cancer stem cells via an endothelial cell intermediate. Stem Cells 28:1019\u20131029","journal-title":"Stem Cells"},{"key":"2_CR39","doi-asserted-by":"publisher","first-page":"3560","DOI":"10.1158\/0008-5472.CAN-06-4238","volume":"67","author":"C Folkins","year":"2007","unstructured":"Folkins C et al (2007) Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors. Cancer Res 67:3560\u20133564","journal-title":"Cancer Res"},{"key":"2_CR40","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1126\/science.1073823","volume":"298","author":"NB Ivanova","year":"2002","unstructured":"Ivanova NB et al (2002) A stem cell molecular signature. Science 298:601\u2013604","journal-title":"Science"},{"key":"2_CR41","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.stem.2010.07.007","volume":"7","author":"A Mohyeldin","year":"2010","unstructured":"Mohyeldin A, Garz\u00f3n-Muvdi T, Qui\u00f1ones-Hinojosa A (2010) Oxygen in stem cell biology: a critical component of the stem cell niche. Cell Stem Cell 7:150\u2013161","journal-title":"Cell Stem Cell"},{"key":"2_CR42","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1056\/NEJM200002243420801","volume":"342","author":"S Braun","year":"2000","unstructured":"Braun S et al (2000) Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med 342:525\u2013533","journal-title":"N Engl J Med"},{"key":"2_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1631\/jzus.B1300264","volume":"15","author":"X Jiang","year":"2014","unstructured":"Jiang X (2014) Harnessing the immune system for the treatment of breast cancer. J Zhejiang Univ Sci B 15:1\u201315","journal-title":"J Zhejiang Univ Sci B"},{"key":"2_CR44","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140:883\u2013899","journal-title":"Cell"},{"key":"2_CR45","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/jnci\/djn123","volume":"100","author":"X Li","year":"2008","unstructured":"Li X et al (2008) Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst 100:672\u2013679","journal-title":"J Natl Cancer Inst"},{"key":"2_CR46","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1172\/JCI39397","volume":"120","author":"C Ginestier","year":"2010","unstructured":"Ginestier C et al (2010) CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J Clin Invest 120:485\u2013497","journal-title":"J Clin Invest"},{"key":"2_CR47","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1158\/1078-0432.CCR-11-3326","volume":"19","author":"AF Schott","year":"2013","unstructured":"Schott AF et al (2013) Preclinical and clinical studies of Gamma Secretase Inhibitors with Docetaxel on human breast tumors. Clin Cancer Res 19:1512\u20131524","journal-title":"Clin Cancer Res"},{"key":"2_CR48","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nature01587","volume":"423","author":"I-k Park","year":"2003","unstructured":"Park I-k et al (2003) Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 423:302\u2013305","journal-title":"Nature"},{"key":"2_CR49","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nature01572","volume":"23","author":"J Lessard","year":"2003","unstructured":"Lessard J, Sauvageau G (2003) Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 23:255\u2013260","journal-title":"Nature"},{"key":"2_CR50","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/nature02060","volume":"425","author":"AV Molofsky","year":"2003","unstructured":"Molofsky AV et al (2003) Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 425:962\u2013967","journal-title":"Nature"},{"key":"2_CR51","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/modpathol.2008.17","volume":"21","author":"IM Bachmann","year":"2008","unstructured":"Bachmann IM et al (2008) Loss of BMI-1 expression is associated with clinical progress of malignant melanoma. Mod Pathol 21:583\u2013590","journal-title":"Mod Pathol"},{"key":"2_CR52","doi-asserted-by":"publisher","first-page":"34696","DOI":"10.1074\/jbc.M604009200","volume":"281","author":"H Cui","year":"2006","unstructured":"Cui H et al (2006) Bmi-1 regulates the differentiation and clonogenic self-renewal of I-type neuroblastoma cells in a concentration-dependent manner. J Biol Chem 281:34696\u201334704","journal-title":"J Biol Chem"},{"key":"2_CR53","doi-asserted-by":"publisher","first-page":"9125","DOI":"10.1158\/0008-5472.CAN-08-2629","volume":"68","author":"J Godlewski","year":"2008","unstructured":"Godlewski J et al (2008) Targeting of the Bmi-1 oncogene\/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res 68:9125\u20139130","journal-title":"Cancer Res"},{"key":"2_CR54","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nm.3418","volume":"20","author":"A Kreso","year":"2014","unstructured":"Kreso A et al (2014) Self-renewal as a therapeutic target in human colorectal cancer. Nat Med 20:29\u201336","journal-title":"Nat Med"},{"key":"2_CR55","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/aps.2013.27","volume":"34","author":"K Chen","year":"2013","unstructured":"Chen K, Huang YH, Chen JI (2013) Understanding and targeting cancer stem cells: therapeutic implications and challenges. Acta Pharmacol Sin 34:732\u2013740","journal-title":"Acta Pharmacol Sin"},{"key":"2_CR56","doi-asserted-by":"publisher","first-page":"7723","DOI":"10.1158\/0008-5472.CAN-09-4360","volume":"70","author":"X Xia","year":"2010","unstructured":"Xia X et al (2010) Image-based chemical screening identifies drug efflux inhibitors in lung cancer cells. Cancer Res 70:7723\u20137733","journal-title":"Cancer Res"},{"key":"2_CR57","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","volume":"1","author":"C Ginestier","year":"2007","unstructured":"Ginestier C et al (2007) ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1:555\u2013567","journal-title":"Cell Stem Cell"},{"key":"2_CR58","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10549-011-1692-y","volume":"133","author":"AK Croker","year":"2012","unstructured":"Croker AK, Allan AL (2012) Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44+ human breast cancer cells. Breast Cancer Res Treat 133:75\u201387","journal-title":"Breast Cancer Res Treat"},{"key":"2_CR59","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1634\/stemcells.2008-0601","volume":"26","author":"G Rappa","year":"2008","unstructured":"Rappa G, Fodstad O, Lorico A (2008) The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma. Stem Cells 26:3008\u20133017","journal-title":"Stem Cells"},{"key":"2_CR60","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/sj.bjc.6604437","volume":"99","author":"LM Smith","year":"2008","unstructured":"Smith LM et al (2008) CD133\/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers. Br J Cancer 99:100\u2013109","journal-title":"Br J Cancer"},{"key":"2_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002751","volume":"8","author":"S Liu","year":"2012","unstructured":"Liu S et al (2012) MicroRNA93 regulates proliferation and differentiation of normal and malignant breast stem cells. PLoS Genet 8, e1002751","journal-title":"PLoS Genet"},{"key":"2_CR62","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nm.2284","volume":"17","author":"C Liu","year":"2011","unstructured":"Liu C et al (2011) The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med 17:211\u2013215","journal-title":"Nat Med"},{"key":"2_CR63","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3390\/cancers5020320","volume":"5","author":"N Sadri","year":"2013","unstructured":"Sadri N, Zhang P (2013) Hypoxia-inducible factors: mediators of cancer progression; prognostic and therapeutic targets in soft tissue sarcomas. Cancers 5:320\u2013333","journal-title":"Cancers"},{"key":"2_CR64","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1073\/pnas.1018866109","volume":"109","author":"SJ Conley","year":"2012","unstructured":"Conley SJ et al (2012) Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia. Proc Natl Acad Sci U S A 109:2784\u20132789","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2_CR65","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4081\/oncol.2011.177","volume":"5","author":"J Wenger","year":"2011","unstructured":"Wenger J et al (2011) Can we develop effective combination antiangiogenic therapy for patients with hepatocellular carcinoma? Oncol Rev 5:177\u2013184","journal-title":"Oncol Rev"},{"key":"2_CR66","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1172\/JCI58976","volume":"122","author":"F Maione","year":"2012","unstructured":"Maione F et al (2012) Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice. J Clin Invest 122:1832\u20131848","journal-title":"J Clin Invest"},{"key":"2_CR67","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.molonc.2010.06.001","volume":"4","author":"MAG Essers","year":"2010","unstructured":"Essers MAG, Trumpp A (2010) Targeting leukemic stem cells by breaking their dormancy. Mol Oncol 4:443\u2013450","journal-title":"Mol Oncol"},{"key":"2_CR68","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1093\/annonc\/mdl074","volume":"17","author":"C Massard","year":"2006","unstructured":"Massard C, Deutsch E, Soria JC (2006) Tumour stem cell-targeted treatment: elimination or differentiation. Ann Oncol 17:1620\u20131624","journal-title":"Ann Oncol"},{"key":"2_CR69","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/labinvest.2008.14","volume":"88","author":"M Shipitsin","year":"2008","unstructured":"Shipitsin M, Polyak K (2008) The cancer stem cell hypothesis: in search of definitions, markers, and relevance. Lab Invest 88:459\u2013463","journal-title":"Lab Invest"},{"key":"2_CR70","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/2001-1326-3-19","volume":"3","author":"K Weina","year":"2014","unstructured":"Weina K, Utikal J (2014) SOX2 and cancer: current research and its implications in the clinic. Clin Transl Med 3:19","journal-title":"Clin Transl Med"},{"key":"2_CR71","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/nature13305","volume":"511","author":"S Boumahdi","year":"2014","unstructured":"Boumahdi S et al (2014) SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma. Nature 511:246\u2013250","journal-title":"Nature"}],"container-title":["International Manual of Oncology Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-21683-6_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T18:58:13Z","timestamp":1676487493000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-319-21683-6_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"ISBN":["9783319216829","9783319216836"],"references-count":71,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-21683-6_2","relation":{},"subject":[],"published":{"date-parts":[[2015]]}}}